Page last updated: 2024-08-25

6-amino-1-hydroxyhexane-1,1-diphosphonate and Age-Related Osteoporosis

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Age-Related Osteoporosis in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (37.50)29.6817
2010's5 (31.25)24.3611
2020's5 (31.25)2.80

Authors

AuthorsStudies
Al Khayyat, SG; Baldi, C; Bardelli, M; Cantarini, L; Conticini, E; D'Alessandro, R; Falsetti, P; Frediani, B; Gentileschi, S; Nicosia, A1
Bardelli, M; Cantarini, L; Frediani, B; Gaggiano, C; Gentileschi, S; Grosso, S; Maselli, A; Tarsia, M1
Baldi, C; Bardelli, M; Cantarini, L; Conticini, E; D'Alessandro, R; Falsetti, P; Frediani, B; Gentileschi, S1
Iolascon, G; Moretti, A1
Bhardwaj, A; Sinha, NK; Swe, KMM1
Amling, M; Barvencik, F; Butscheidt, S; Denecke, J; Jeschke, A; Kubisch, C; Meisler, MH; Neu, A; Oheim, R; Pueschel, K; Rolvien, T; Schinke, T; Yorgan, T1
Bhardwaj, A; Osunkwo, I; Sinha, NK; Swe, KM1
Celli, M; D'Eufemia, P; Finocchiaro, R; Iacobini, M; Raccio, I; Smacchia, P; Tetti, M; Zambrano, A1
Carda, S; Cisari, C; Invernizzi, M; Sainaghi, PP1
Baldini, M; Borgna Pignatti, C; Cappellini, MD; D'Ascola, DG; Filosa, A; Forni, GL; Giusti, A; Iolascon, G; Nobili, B; Palummeri, E; Perrotta, S; Pinto, V; Pitrolo, L; Quarta, G; Rigano, P; Rosa, A1
La Montagna, G; Malesci, D; Tirri, R; Valentini, G1
Anastasi, G; Atteritano, M; Catalano, A; Frisina, N; Gaudio, A; Lasco, A; Melloni, D; Morabito, N; Trifiletti, A1
Anastasi, G; Franchina, F; Frisina, N; Galì, A; Gaudio, A; Magno, C; Maisano, D; Melloni, D; Morabito, N1
Bifulco, G; Cascella, T; Colao, A; Lombardi, G; Musella, T; Nappi, C; Orio, F; Palomba, S; Tauchmanova, L1
Cantatore, FP; Colucci, S; Corrado, A; Grano, M1
Benucci, M; Dolenti, S; Manfredi, M; Saviola, G1

Reviews

3 review(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Age-Related Osteoporosis

ArticleYear
The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain.
    International journal of molecular sciences, 2022, Jun-22, Volume: 23, Issue:13

    Topics: Bone Density; Child; Diphosphonates; Humans; Musculoskeletal Pain; Osteoporosis

2022
Treatment for osteoporosis in people with beta-thalassaemia.
    The Cochrane database of systematic reviews, 2023, 05-09, Volume: 5

    Topics: Adult; Alendronate; beta-Thalassemia; Child; Clodronic Acid; Denosumab; Diphosphonates; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Pamidronate

2023
Treatment for osteoporosis in people with ß-thalassaemia.
    The Cochrane database of systematic reviews, 2016, Mar-10, Volume: 3

    Topics: Adolescent; Adult; Alendronate; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Child; Clodronic Acid; Diphosphonates; Female; Femur Neck; Humans; Male; Middle Aged; Osteoporosis; Randomized Controlled Trials as Topic; Zinc Sulfate

2016

Trials

6 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Age-Related Osteoporosis

ArticleYear
Taurine deficiency in thalassemia major-induced osteoporosis treated with neridronate.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:4

    Topics: Adult; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Follow-Up Studies; Humans; Male; Osteoporosis; Taurine; Time Factors; Young Adult

2010
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.
    British journal of haematology, 2012, Volume: 158, Issue:2

    Topics: Adolescent; Adult; Alkaline Phosphatase; Back Pain; beta-Thalassemia; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type I; Diphosphonates; Female; Femur Neck; Hip Joint; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Peptides; Quality of Life; Treatment Outcome; Young Adult

2012
Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:11

    Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Density; Calcium; Cholecalciferol; Diphosphonates; Humans; Male; Osteoporosis; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate

2004
Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate.
    European urology, 2005, Volume: 47, Issue:5

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Androgen Antagonists; Anilides; Biomarkers; Bone Density; Calcium; Chromatography, High Pressure Liquid; Diphosphonates; Drug Therapy, Combination; Estradiol; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Nitriles; Osteoporosis; Parathyroid Hormone; Phosphorus; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Outcome; Vitamin D

2005
Effects of neridronate treatment in elderly women with osteoporosis.
    Journal of endocrinological investigation, 2005, Volume: 28, Issue:3

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Diphosphonates; Female; Humans; Male; Osteoporosis; Pilot Projects; Quality of Life

2005
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Recenti progressi in medicina, 2006, Volume: 97, Issue:1

    Topics: Aged; Arthritis, Rheumatoid; Bone Resorption; Calcium; Data Interpretation, Statistical; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Middle Aged; Osteoporosis; Polymyalgia Rheumatica; Sjogren's Syndrome; Time Factors; Treatment Outcome; Vitamin D

2006

Other Studies

7 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Age-Related Osteoporosis

ArticleYear
Efficacy of intravenous neridronate in transient osteoporosis of the hip.
    Clinical and experimental rheumatology, 2022, Volume: 40, Issue:9

    Topics: Acute Disease; Diphosphonates; Female; Humans; Male; Middle Aged; Osteoporosis; Pain; Retrospective Studies

2022
Neridronate for transient osteoporosis of the hip in a child.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2022, Volume: 33, Issue:7

    Topics: Child; Diphosphonates; Female; Hip Joint; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteoporosis; Pregnancy; Quality of Life

2022
Intravenous neridronate is effective in regional migratory osteoporosis.
    Rheumatology (Oxford, England), 2022, 10-06, Volume: 61, Issue:10

    Topics: Diphosphonates; Humans; Osteoporosis

2022
Severe bone loss and multiple fractures in SCN8A-related epileptic encephalopathy.
    Bone, 2017, Volume: 103

    Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Child; Diphosphonates; Female; Fractures, Multiple; Humans; Infant; Mice; Mice, Knockout; Mutation; NAV1.6 Voltage-Gated Sodium Channel; Osteoporosis; Spasms, Infantile

2017
Acute pseudogout following intravenous neridronate for osteoporosis.
    The Journal of rheumatology, 2010, Volume: 37, Issue:5

    Topics: Acute Disease; Aged, 80 and over; Chondrocalcinosis; Diphosphonates; Female; Humans; Osteoporosis

2010
Successful neridronate therapy in transient osteoporosis of the hip.
    Clinical rheumatology, 2005, Volume: 24, Issue:1

    Topics: Adult; Arthrography; Diphosphonates; Female; Follow-Up Studies; Hip Joint; Humans; Injections, Intramuscular; Magnetic Resonance Imaging; Osteoporosis; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2005
Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects.
    Clinical rheumatology, 2005, Volume: 24, Issue:5

    Topics: Adult; Aged; Cells, Cultured; Cholecalciferol; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Osteoarthritis; Osteoblasts; Osteocalcin; Osteoporosis

2005